Interferon-α plus ribavirin for 12 months increases the sustained response rates in chronic hepatitis C relapsers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Interferon-α plus ribavirin for 12 months increases the sustained response rates in chronic hepatitis C relapsers

Published:2002-01-18 Issue:2 Volume:16 Page:243-249
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:

Author:

Moreno-Monteagudo J. A.,Castro A.,De Pedro A.,Lorenzo J. A.,Fernández-Bermejo M.,Lopez S.,García-Buey L.,Borque M. J.,Pedreira J. D.,Moreno-Otero R.

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2036.2002.01162.x/fullpdf

Reference23 articles.

1. Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT);Poynard;Lancet,1998

2. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group;McHutchison;N Engl J Med,1998

3. Interferon-alpha-2B and ribavirin in combination for chronic hepatitis C patients not responding to interferon-alpha alone: an Italian multicenter, randomized, controlled, clinical study;Barbaro;Am J Gastroenterol,1998

4. Recombinant interferon alfa-2b alone or in combination with ribavirin for retreatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group;Davis;N Engl J Med,1998

5. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis;Knodell;Hepatology,1981

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Usefulness of simple biomarkers at admission as independent indicators and predictors of in-hospital mortality in older hip fracture patients;Injury;2018-04

2. The effects of a maintenance therapy with peg-interferon alpha-2a on liver fibrosis in HIV/HCV co-infected patients: A randomized controlled trial;Journal of Infection;2013-10

3. A Cell-Based Assay for RNA Synthesis by the HCV Polymerase Reveals New Insights on Mechanism of Polymerase Inhibitors and Modulation by NS5A;PLoS ONE;2011-07-22

4. Combination Therapy of Interferon and Ribavirin Versus Interferon Monotherapy in Treatment of Chronic Hepatitis C: A Meta-analysis of Clinical Trials;Journal of Pharmacy Practice;2006-10

5. Therapeutic modalities in hepatitis C: challenges and development;Journal of Viral Hepatitis;2005-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3